(NASDAQ: SEER) Seer's forecast annual revenue growth rate of 22.94% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 30.45%, and while it is forecast to beat the US market's average forecast revenue growth rate of 13.33%.
Seer's revenue in 2026 is $14,217,000.On average, 4 Wall Street analysts forecast SEER's revenue for 2026 to be $909,319,230, with the lowest SEER revenue forecast at $868,233,195, and the highest SEER revenue forecast at $941,877,975. On average, 4 Wall Street analysts forecast SEER's revenue for 2027 to be $1,095,701,433, with the lowest SEER revenue forecast at $949,630,057, and the highest SEER revenue forecast at $1,238,395,115.
In 2028, SEER is forecast to generate $1,462,817,892 in revenue, with the lowest revenue forecast at $1,269,791,048 and the highest revenue forecast at $1,651,193,487.